Celularity Average Payables Over Time
| CELU Stock | USD 2.76 0.09 3.16% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Celularity Performance and Celularity Correlation. Celularity |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (104.78) | Revenue Per Share 2.099 | Quarterly Revenue Growth 3.122 | Return On Assets (0.15) |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Average Payables Analysis
Compare Celularity and related stocks such as Immix Biopharma, ZyVersa Therapeutics, and Hepion Pharmaceuticals Average Payables Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ZVSA | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 4 M | 3.6 M | 3.2 M |
| HEPA | 123.8 K | 123.8 K | 123.8 K | 123.8 K | 862.6 K | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 620 K | 2.6 M | 2.6 M | 2.6 M | 2.5 M | 2.6 M |
| CNSP | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 617.9 K | 1.5 M | 2.8 M | 2.5 M | 1.3 M |
| SONN | 2.1 M | 105.8 M | 502.2 K | 1.6 M | 1.2 M | 2.1 M | 2.1 M | 3.7 M | 2.1 M | 2 M | 4.3 M | 4.3 M | 3.5 M | 3.7 M | 3.6 M |
Celularity and related stocks such as Immix Biopharma, ZyVersa Therapeutics, and Hepion Pharmaceuticals Average Payables description
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.My Equities
My Current Equities and Potential Positions
| Celularity | CELU |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.76
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.